Table 6.
Test | Geriatric domain | Number of questions | Administration | Score, range |
Cut-off point associated with adverse outcomes |
---|---|---|---|---|---|
Vulnerable elders survey-13 (VES-13) | Functionally based screening measure | 13 | Self-administered (5 min) | 0–10 | ≥3 |
Activities of daily living (ADLs) | Function | 8 | Self-administered (5–10 min) | 0–16 | ≤14 |
Instrumental activities of daily living (IADLs) | Function | 7 | Self-administered (5–10 min) | 0–14 | ≤12 |
Short Physical Performance Battery (SPPB) | Objective evaluation of function/physical performance | Three separate physical performance tests | Administered by member of research team (10–15 min) | 0–12 | <9 |
CALGBa adaptation Charlson comorbidity score | Comorbidity | 18 | Self-administered (15 min) | 0–54 | >10 |
Number of medications | Comorbidity/toxicity potential from drug interactions | 1 | Self-administered (1–5 min) | 0–∞ | ≥5 |
RAND medical social support scale | Social Support/access to medical care and support | 5 | Self-administered (1–5 min) | 0–5 | <4 |
Short Portable Mental Status Questionnaire | Cognition/risk for dementia | 10 | Administered by member of research team (10–15 min) | 0–10 | >3 |
Cancer and Leukemia Group B.